These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 24382592)
1. Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs. Raina SA; Zhang GGZ; Alonzo DE; Wu J; Zhu D; Catron ND; Gao Y; Taylor LS J Pharm Sci; 2014 Sep; 103(9):2736-2748. PubMed ID: 24382592 [TBL] [Abstract][Full Text] [Related]
2. Exploiting the Phenomenon of Liquid-Liquid Phase Separation for Enhanced and Sustained Membrane Transport of a Poorly Water-Soluble Drug. Indulkar AS; Gao Y; Raina SA; Zhang GG; Taylor LS Mol Pharm; 2016 Jun; 13(6):2059-69. PubMed ID: 27138900 [TBL] [Abstract][Full Text] [Related]
3. Impact of Solubilizing Additives on Supersaturation and Membrane Transport of Drugs. Raina SA; Zhang GG; Alonzo DE; Wu J; Zhu D; Catron ND; Gao Y; Taylor LS Pharm Res; 2015 Oct; 32(10):3350-64. PubMed ID: 26017301 [TBL] [Abstract][Full Text] [Related]
4. Using Environment-Sensitive Fluorescent Probes to Characterize Liquid-Liquid Phase Separation in Supersaturated Solutions of Poorly Water Soluble Compounds. Raina SA; Alonzo DE; Zhang GG; Gao Y; Taylor LS Pharm Res; 2015 Nov; 32(11):3660-73. PubMed ID: 26123681 [TBL] [Abstract][Full Text] [Related]
5. pH-Dependent Liquid-Liquid Phase Separation of Highly Supersaturated Solutions of Weakly Basic Drugs. Indulkar AS; Box KJ; Taylor R; Ruiz R; Taylor LS Mol Pharm; 2015 Jul; 12(7):2365-77. PubMed ID: 25984769 [TBL] [Abstract][Full Text] [Related]
6. Mechanistic understanding of the phase behavior of supersaturated solutions of poorly water-soluble drugs. Tres F; Posada MM; Hall SD; Mohutsky MA; Taylor LS Int J Pharm; 2018 May; 543(1-2):29-37. PubMed ID: 29572154 [TBL] [Abstract][Full Text] [Related]
7. Glass-liquid phase separation in highly supersaturated aqueous solutions of telaprevir. Mosquera-Giraldo LI; Taylor LS Mol Pharm; 2015 Feb; 12(2):496-503. PubMed ID: 25541813 [TBL] [Abstract][Full Text] [Related]
8. Physical chemistry of supersaturated solutions and implications for oral absorption. Taylor LS; Zhang GGZ Adv Drug Deliv Rev; 2016 Jun; 101():122-142. PubMed ID: 27013254 [TBL] [Abstract][Full Text] [Related]
9. Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products. Trasi NS; Taylor LS J Pharm Sci; 2015 Aug; 104(8):2583-93. PubMed ID: 26059413 [TBL] [Abstract][Full Text] [Related]
10. Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations. Alhalaweh A; Bergström CAS; Taylor LS J Control Release; 2016 May; 229():172-182. PubMed ID: 27006280 [TBL] [Abstract][Full Text] [Related]
11. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion. Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060 [TBL] [Abstract][Full Text] [Related]
12. Insight into Amorphous Solid Dispersion Performance by Coupled Dissolution and Membrane Mass Transfer Measurements. Hate SS; Reutzel-Edens SM; Taylor LS Mol Pharm; 2019 Jan; 16(1):448-461. PubMed ID: 30521350 [TBL] [Abstract][Full Text] [Related]
13. Monitoring the Phase Behavior of Supersaturated Solutions of Poorly Water-Soluble Drugs Using Fluorescence Techniques. Tres F; Hall SD; Mohutsky MA; Taylor LS J Pharm Sci; 2018 Jan; 107(1):94-102. PubMed ID: 29031978 [TBL] [Abstract][Full Text] [Related]
14. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type. Jackson MJ; Kestur US; Hussain MA; Taylor LS Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions. Jackson MJ; Kestur US; Hussain MA; Taylor LS Pharm Res; 2016 May; 33(5):1276-88. PubMed ID: 26892947 [TBL] [Abstract][Full Text] [Related]
16. Equilibrium state at supersaturated drug concentration achieved by hydroxypropyl methylcellulose acetate succinate: molecular characterization using (1)H NMR technique. Ueda K; Higashi K; Yamamoto K; Moribe K Mol Pharm; 2015 Apr; 12(4):1096-104. PubMed ID: 25723893 [TBL] [Abstract][Full Text] [Related]
17. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Konno H; Handa T; Alonzo DE; Taylor LS Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451 [TBL] [Abstract][Full Text] [Related]
18. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. Lakshman JP; Cao Y; Kowalski J; Serajuddin AT Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852 [TBL] [Abstract][Full Text] [Related]
19. Toward Developing Discriminating Dissolution Methods for Formulations Containing Nanoparticulates in Solution: The Impact of Particle Drift and Drug Activity in Solution. Arce FA; Setiawan N; Campbell HR; Lu X; Nethercott MJ; Bummer P; Su Y; Marsac PJ Mol Pharm; 2020 Nov; 17(11):4125-4140. PubMed ID: 32965123 [TBL] [Abstract][Full Text] [Related]
20. Phase separation of supersaturated solution created from amorphous solid dispersions: Relevance to oral absorption. Kawakami K; Sato K; Fukushima M; Miyazaki A; Yamamura Y; Sakuma S Eur J Pharm Biopharm; 2018 Nov; 132():146-156. PubMed ID: 30253186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]